VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q37367472  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000320.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q37367472‏
024 ‎‡a  0000-0001-9222-3882‏ ‎‡2  orcid‏
024 ‎‡a  6602647416‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q37367472‏
100 0 ‎‡a  Ana Cristina Simões E Silva‏ ‎‡c  investigadora‏ ‎‡9  ast‏
375 ‎‡a  2‏ ‎‡2  iso5218‏
400 0 ‎‡a  Ana Cristina Simões E Silva‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Ana Cristina Simões E Silva‏ ‎‡c  investigadora‏ ‎‡9  es‏
400 0 ‎‡a  Ana Cristina Simões E. Silva‏ ‎‡c  ricercatrice‏ ‎‡9  it‏
400 0 ‎‡a  Ana Cristina Simões E Silva‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
400 0 ‎‡a  Ana Cristina Simões E Silva‏ ‎‡c  investigadora‏ ‎‡9  pt‏
670 ‎‡a  Author's 2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus‏
670 ‎‡a  Author's A clinical predictive model of renal injury in children with congenital solitary functioning kidney‏
670 ‎‡a  Author's A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis‏
670 ‎‡a  Author's A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract‏
670 ‎‡a  Author's A Predictive Model of Postnatal Surgical Intervention in Children With Prenatally Detected Congenital Anomalies of the Kidney and Urinary Tract‏
670 ‎‡a  Author's A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program‏
670 ‎‡a  Author's A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome‏
670 ‎‡a  Author's A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates‏
670 ‎‡a  Author's ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis‏
670 ‎‡a  Author's ACE2–angiotensin-‏
670 ‎‡a  Author's ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats‏
670 ‎‡a  Author's ACE2/Angiotensin-(1-7)/Mas receptor axis in human cancer: Potential role for pediatric tumors‏
670 ‎‡a  Author's Action of a pancreatin and an Aspergillus oryzae protease on whey proteins: correlation among the methods of analysis of the enzymatic hydrolysates‏
670 ‎‡a  Author's ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation‏
670 ‎‡a  Author's Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas‏
670 ‎‡a  Author's Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors‏
670 ‎‡a  Author's Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney‏
670 ‎‡a  Author's Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress‏
670 ‎‡a  Author's Angiotensins‏
670 ‎‡a  Author's Anthropometric and biochemical profile of children and adolescents with chronic kidney disease in a predialysis pediatric interdisciplinary program.‏
670 ‎‡a  Author's Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis‏
670 ‎‡a  Author's Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.‏
670 ‎‡a  Author's Aplicação da biologia molecular na abordagem da síndrome de Bartter: relato de caso‏
670 ‎‡a  Author's Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging‏
670 ‎‡a  Author's Association between dyslipidemia and CCL2 in patients undergoing hemodialysis‏
670 ‎‡a  Author's Association of angiotensin type 2 receptor gene polymorphisms with ureteropelvic junction obstruction in Brazilian patients‏
670 ‎‡a  Author's Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract‏
670 ‎‡a  Author's Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and Adolescents‏
670 ‎‡a  Author's Avaliação da dor em neonatologia‏
670 ‎‡a  Author's [Bartter' syndrome: five cases with different clinical expression]‏
670 ‎‡a  Author's Bartter's syndrome: clinical findings, genetic causes and therapeutic approach‏
670 ‎‡a  Author's Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease‏
670 ‎‡a  Author's Beneficial effects of the activation of the angiotensin-‏
670 ‎‡a  Author's Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.‏
670 ‎‡a  Author's Biomarkers in vesicoureteral reflux: an overview‏
670 ‎‡a  Author's Bone disease and cytokines in idiopathic hypercalciuria: a review‏
670 ‎‡a  Author's Cell-derived microparticles and von Willebrand factor in Brazilian renal transplant recipients‏
670 ‎‡a  Author's Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer’s Disease‏
670 ‎‡a  Author's Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7).‏
670 ‎‡a  Author's Characterization of an experimental model of progressive renal disease in rats‏
670 ‎‡a  Author's Chemokines as Potential Markers in Pediatric Renal Diseases‏
670 ‎‡a  Author's Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity‏
670 ‎‡a  Author's Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-‏
670 ‎‡a  Author's Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease‏
670 ‎‡a  Author's Citocinas e quimiocinas no transplante renal‏
670 ‎‡a  Author's Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome‏
670 ‎‡a  Author's Clinical course of 822 children with prenatally detected nephrouropathies‏
670 ‎‡a  Author's Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program‏
670 ‎‡a  Author's Combined Use of Late Phase Dimercapto-Succinic Acid Renal Scintigraphy and Ultrasound as First Line Screening After Urinary Tract Infection in Children‏
670 ‎‡a  Author's Comparison of Brazilian researchers in clinical medicine: are criteria for ranking well-adjusted?‏
670 ‎‡a  Author's Congenital anomalies of the kidney and urinary tract: an embryogenetic review‏
670 ‎‡a  Author's Current knowledge on esophageal atresia‏
670 ‎‡a  Author's Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis.‏
670 ‎‡a  Author's Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases‏
670 ‎‡a  Author's Dental Alterations in Renal Tubular Acidosis: Case Reports‏
670 ‎‡a  Author's Dental findings in Brazilian patients with Fanconi syndrome‏
670 ‎‡a  Author's Dental Manifestations in Two Patients With Bartter’s Syndrome‏
670 ‎‡a  Author's Development of hepatorenal syndrome in bile duct ligated rats‏
670 ‎‡a  Author's Diagnostic accuracy of renal pelvic dilatation for detecting surgically managed ureteropelvic junction obstruction‏
670 ‎‡a  Author's Diagnostic criteria for autoimmune hepatitis in children: a challenge for pediatric hepatologists‏
670 ‎‡a  Author's Distal renal tubular acidosis: genetic causes and management‏
670 ‎‡a  Author's Diuresis and natriuresis produced by long term administration of a selective Angiotensin-‏
670 ‎‡a  Author's Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats‏
670 ‎‡a  Author's Early awakening and extubation with remifentanil in ventilated premature neonates‏
670 ‎‡a  Author's Early changes in adipokines from overweight to obesity in children and adolescents.‏
670 ‎‡a  Author's Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns‏
670 ‎‡a  Author's Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease‏
670 ‎‡a  Author's Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients‏
670 ‎‡a  Author's Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-‏
670 ‎‡a  Author's Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats‏
670 ‎‡a  Author's Enzymatic hydrolysis of whey protein concentrate: effect of enzyme type and enzyme:substrate ratio on peptide profile‏
670 ‎‡a  Author's Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy‏
670 ‎‡a  Author's Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients‏
670 ‎‡a  Author's Evidence for a Physiological Role of Angiotensin-‏
670 ‎‡a  Author's Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance‏
670 ‎‡a  Author's Evidence for a role of Angiotensin Converting Enzyme 2 in proteinuria of idiopathic nephrotic syndrome‏
670 ‎‡a  Author's Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia‏
670 ‎‡a  Author's First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection.‏
670 ‎‡a  Author's Frequency of overweight and obesity in children and adolescents with autism and attention deficit/hyperactivity disorder‏
670 ‎‡a  Author's Genetic deletion of the angiotensin-‏
670 ‎‡a  Author's Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.‏
670 ‎‡a  Author's Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors‏
670 ‎‡a  Author's Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.‏
670 ‎‡a  Author's Hemostatic changes in patients with end stage renal disease undergoing hemodialysis‏
670 ‎‡a  Author's Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients‏
670 ‎‡a  Author's Hepatorenal syndrome in children: a review‏
670 ‎‡a  Author's Imaging for evaluation of urologic abnormalities in infants with fetal hydronephrosis: advances and controversies‏
670 ‎‡a  Author's Immune-Based Therapies for Traumatic Brain Injury: Insights from pre-clinical studies‏
670 ‎‡a  Author's Immune markers in the RASopathy neurofibromatosis type 1.‏
670 ‎‡a  Author's Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria‏
670 ‎‡a  Author's Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study.‏
670 ‎‡a  Author's Immunoglobulin A nephropathy: a pathophysiology view‏
670 ‎‡a  Author's Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients‏
670 ‎‡a  Author's [In memoriam: Professor José Silvério Santos Diniz‏
670 ‎‡a  Author's [In memoriam: Professor José Silvério Santos Diniz (1935-2011)].‏
670 ‎‡a  Author's Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome‏
670 ‎‡a  Author's Inflamação na doença renal crônica: papel de citocinas‏
670 ‎‡a  Author's Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review.‏
670 ‎‡a  Author's Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis‏
670 ‎‡a  Author's Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease‏
670 ‎‡a  Author's Interactions between local renin angiotensin system and nitric oxide in the brain of Trypanosoma cruzi infected rats‏
670 ‎‡a  Author's Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?‏
670 ‎‡a  Author's Is remifentanil an option for premedication for neonatal endotracheal intubation?‏
670 ‎‡a  Author's Is there a correlation between journal impact factor and researchers’ performance? A study comprising the fields of clinical nephrology and neurosciences‏
670 ‎‡a  Author's Kidney-brain axis inflammatory cross-talk: from bench to bedside‏
670 ‎‡a  Author's Liddle's syndrome: late diagnosis of a rare cause of arterial hypertension‏
670 ‎‡a  Author's Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia‏
670 ‎‡a  Author's Lower circulating levels of angiotensin-converting enzyme‏
670 ‎‡a  Author's Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia‏
670 ‎‡a  Author's Mas and Inflammation‏
670 ‎‡a  Author's Mas in the Kidney‏
670 ‎‡a  Author's Máscara laríngea ProSealTM como via de administração de surfactante no tratamento da síndrome do desconforto respiratório em recém-nascido pré-termo‏
670 ‎‡a  Author's Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy‏
670 ‎‡a  Author's Morphine versus remifentanil for intubating preterm neonates‏
670 ‎‡a  Author's Neuropsychiatric disorders and renal diseases: an update‏
670 ‎‡a  Author's Neurotrophic Factors in Parkinson's Disease: What have we Learned from Pre-Clinical and Clinical Studies?‏
670 ‎‡a  Author's New method of surgical delayed closure of giant omphaloceles: Lazaro da Silva's technique‏
670 ‎‡a  Author's Newer Doppler echocardiography techniques in assessment of heart function in obese patients‏
670 ‎‡a  Author's Nonpeptide AVE 0991 is an angiotensin-‏
670 ‎‡a  Author's Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.‏
670 ‎‡a  Author's Nutritional evaluation of children with chronic cholestatic disease‏
670 ‎‡a  Author's Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies‏
670 ‎‡a  Author's PAX2 polymorphisms and congenital abnormalities of the kidney and urinary tract in a Brazilian pediatric population: evidence for a role in vesicoureteral reflux‏
670 ‎‡a  Author's Pediatric lupus nephritis‏
670 ‎‡a  Author's Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease‏
670 ‎‡a  Author's Perfil e análise da produção científica dos pesquisadores brasileiros em Neurociência Clínica‏
670 ‎‡a  Author's Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease‏
670 ‎‡a  Author's Physical Exercise and ACE2-Angiotensin-‏
670 ‎‡a  Author's Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System‏
670 ‎‡a  Author's Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals.‏
670 ‎‡a  Author's Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria‏
670 ‎‡a  Author's Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: a preliminary study‏
670 ‎‡a  Author's Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules‏
670 ‎‡a  Author's Posterior urethral valves: comparison of clinical outcomes between postnatal and antenatal cohorts‏
670 ‎‡a  Author's Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease‏
670 ‎‡a  Author's Predictive factors of chronic kidney disease in severe vesicoureteral reflux‏
670 ‎‡a  Author's Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme‏
670 ‎‡a  Author's Primary versus secondary hypertension in children followed up at an outpatient tertiary unit‏
670 ‎‡a  Author's Profile and scientific output of researchers recipients of CNPq productivity grant in the field of medicine‏
670 ‎‡a  Author's Profile and scientific production of the Brazilian Council for Scientific and Technological Development (CNPq) researchers in the field of Hematology/Oncology‏
670 ‎‡a  Author's RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders‏
670 ‎‡a  Author's Recent advances in the angiotensin-converting enzyme 2-angiotensin‏
670 ‎‡a  Author's Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.‏
670 ‎‡a  Author's Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis‏
670 ‎‡a  Author's Relationship between angiotensin-‏
670 ‎‡a  Author's Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis‏
670 ‎‡a  Author's Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome‏
670 ‎‡a  Author's Renal actions of angiotensin-‏
670 ‎‡a  Author's Renal actions of angiotensin-(1-7).‏
670 ‎‡a  Author's Renal function in transgenic rats expressing an angiotensin-‏
670 ‎‡a  Author's Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein‏
670 ‎‡a  Author's Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade‏
670 ‎‡a  Author's Renin-angiotensin system and Alzheimer's disease pathophysiology: From the potential interactions to therapeutic perspectives‏
670 ‎‡a  Author's Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence‏
670 ‎‡a  Author's Renin angiotensin system in liver diseases: Friend or foe?‏
670 ‎‡a  Author's Renin-angiotensin system in the pathogenesis of liver fibrosis‏
670 ‎‡a  Author's Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19‏
670 ‎‡a  Author's Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury.‏
670 ‎‡a  Author's Risk factors for early onset of diabetic nephropathy in pediatric type 1 diabetes‏
670 ‎‡a  Author's Risk factors for recurrent urinary tract infections in a cohort of patients with primary vesicoureteral reflux.‏
670 ‎‡a  Author's Risk of hypertension in primary vesicoureteral reflux‏
670 ‎‡a  Author's [Sedation and analgesia in neonatology.].‏
670 ‎‡a  Author's Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis‏
670 ‎‡a  Author's Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients‏
670 ‎‡a  Author's Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease‏
670 ‎‡a  Author's Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract‏
670 ‎‡a  Author's Successful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy.‏
670 ‎‡a  Author's T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome‏
670 ‎‡a  Author's The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research‏
670 ‎‡a  Author's The copy number variation landscape of congenital anomalies of the kidney and urinary tract‏
670 ‎‡a  Author's The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update‏
670 ‎‡a  Author's The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy‏
670 ‎‡a  Author's The pregnancy-induced increase of plasma angiotensin-‏
670 ‎‡a  Author's The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes‏
670 ‎‡a  Author's The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves‏
670 ‎‡a  Author's The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease‏
670 ‎‡a  Author's The Renin Angiotensin System and Bipolar Disorder: A Systematic Review‏
670 ‎‡a  Author's The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence‏
670 ‎‡a  Author's The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-‏
670 ‎‡a  Author's The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)‏
670 ‎‡a  Author's The renin angiotensin system in childhood hypertension: selective increase of angiotensin-‏
670 ‎‡a  Author's The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.‏
670 ‎‡a  Author's The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood‏
670 ‎‡a  Author's The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies‏
670 ‎‡a  Author's The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator‏
670 ‎‡a  Author's The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders‏
670 ‎‡a  Author's Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter's Syndrome‏
670 ‎‡a  Author's Update on the approach of urinary tract infection in childhood‏
670 ‎‡a  Author's Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study‏
670 ‎‡a  Author's Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.‏
670 ‎‡a  Author's Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies‏
670 ‎‡a  Author's Urinary tract infection in pediatrics: an overview‏
670 ‎‡a  Author's Uromodulin: a new biomarker of fetal renal function?‏
670 ‎‡a  Author's Use of Different Proteases to Obtain Whey Protein Concentrate Hydrolysates with Inhibitory Activity toward Angiotensin-Converting Enzyme‏
670 ‎‡a  Author's Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report‏
670 ‎‡a  Author's Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study‏
670 ‎‡a  Author's Whole-exome sequencing as a diagnostic tool for distal renal tubular acidosis‏
670 ‎‡a  Author's Zika virus challenges for neuropsychiatry‏
909 ‎‡a  (orcid) 0000000192223882‏ ‎‡9  1‏
909 ‎‡a  (scopus) 6602647416‏ ‎‡9  1‏
912 ‎‡a  authorcorrectionthecopynumbervariationlandscapeofcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A  Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract‏ ‎‡9  1‏
912 ‎‡a  copynumbervariationlandscapeofcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A  The copy number variation landscape of congenital anomalies of the kidney and urinary tract‏ ‎‡9  1‏
919 ‎‡a  vancomycinassociatednephrotoxicityinnoncriticallyillpatientsadmittedinabrazilianpublichospitalaprospectivecohortstudy‏ ‎‡A  Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study‏ ‎‡9  1‏
919 ‎‡a  wholeexomesequencingasadiagnostictoolfordistalrenaltubularacidosis‏ ‎‡A  Whole-exome sequencing as a diagnostic tool for distal renal tubular acidosis‏ ‎‡9  1‏
919 ‎‡a  zikaviruschallengesforneuropsychiatry‏ ‎‡A  Zika virus challenges for neuropsychiatry‏ ‎‡9  1‏
919 ‎‡a  2020updateonthereninangiotensinaldosteronesysteminpediatrickidneydiseaseanditsinteractionswithcoronavirus‏ ‎‡A  2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus‏ ‎‡9  1‏
919 ‎‡a  clinicalpredictivemodelofrenalinjuryinchildrenwithcongenitalsolitaryfunctioningkidney‏ ‎‡A  A clinical predictive model of renal injury in children with congenital solitary functioning kidney‏ ‎‡9  1‏
919 ‎‡a  clinicalpredictivemodelofrenalinjuryinchildrenwithisolatedantenatalhydronephrosis‏ ‎‡A  A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis‏ ‎‡9  1‏
919 ‎‡a  predictivemodelofchronickidneydiseaseinpatientswithcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A  A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract‏ ‎‡9  1‏
919 ‎‡a  predictivemodelofpostnatalsurgicalinterventioninchildrenwithprenatallydetectedcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A  A Predictive Model of Postnatal Surgical Intervention in Children With Prenatally Detected Congenital Anomalies of the Kidney and Urinary Tract‏ ‎‡9  1‏
919 ‎‡a  predictivemodelofprogressionofckdtoesrdinapredialysispediatricinterdisciplinaryprogram‏ ‎‡A  A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program‏ ‎‡9  1‏
919 ‎‡a  predictivemodelofprogressivechronickidneydiseaseinidiopathicnephroticsyndrome‏ ‎‡A  A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome‏ ‎‡9  1‏
919 ‎‡a  randomizedcontrolledtrialofthelaryngealmaskairwayforsurfactantadministrationinneonates‏ ‎‡A  A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates‏ ‎‡9  1‏
919 ‎‡a  aceinhibitionace2andangiotensin17axisinkidneyandcardiacinflammationandfibrosis‏ ‎‡A  ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis‏ ‎‡9  1‏
919 ‎‡a  ace2angiotensin‏ ‎‡A  ACE2–angiotensin-‏ ‎‡9  1‏
919 ‎‡a  ace2angiotensin17masaxisinrenalischaemiareperfusioninjuryinrats‏ ‎‡A  ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats‏ ‎‡9  1‏
919 ‎‡a  ace2angiotensin17masreceptoraxisinhumancancerpotentialroleforpediatrictumors‏ ‎‡A  ACE2/Angiotensin-(1-7)/Mas receptor axis in human cancer: Potential role for pediatric tumors‏ ‎‡9  1‏
919 ‎‡a  actionofapancreatinandanaspergillusoryzaeproteaseonwheyproteinscorrelationamongthemethodsofanalysisoftheenzymatichydrolysates‏ ‎‡A  Action of a pancreatin and an Aspergillus oryzae protease on whey proteins: correlation among the methods of analysis of the enzymatic hydrolysates‏ ‎‡9  1‏
919 ‎‡a  adamts13andvonwillebrandfactorassessmentbeforeandafterkidneytransplantation‏ ‎‡A  ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation‏ ‎‡9  1‏
919 ‎‡a  angiotensin17isanendogenousligandforthegproteincoupledreceptormas‏ ‎‡A  Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas‏ ‎‡9  1‏
919 ‎‡a  angiotensin17stimulateswatertransportinratinnermedullarycollectingductevidenceforinvolvementofvasopressinv2receptors‏ ‎‡A  Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors‏ ‎‡9  1‏
919 ‎‡a  angiotensinconvertingenzyme2angiotensin17andreceptormasaxisinthekidney‏ ‎‡A  Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney‏ ‎‡9  1‏
919 ‎‡a  angiotensinconvertingenzymeinhibitionchangesthemetabolicresponsetoneuroglucopenicstress‏ ‎‡A  Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress‏ ‎‡9  1‏
919 ‎‡a  angiotensins‏ ‎‡A  Angiotensins‏ ‎‡9  1‏
919 ‎‡a  anthropometricandbiochemicalprofileofchildrenandadolescentswithchronickidneydiseaseinapredialysispediatricinterdisciplinaryprogram‏ ‎‡A  Anthropometric and biochemical profile of children and adolescents with chronic kidney disease in a predialysis pediatric interdisciplinary program.‏ ‎‡9  1‏
919 ‎‡a  antiinflammatoryeffectsoftheactivationoftheangiotensin17receptormasinexperimentalmodelsofarthritis‏ ‎‡A  Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis‏ ‎‡9  1‏
919 ‎‡a  anxietydepressionresilienceandqualityoflifeinchildrenandadolescentswithpredialysischronickidneydisease‏ ‎‡A  Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.‏ ‎‡9  1‏
919 ‎‡a  aplicacaodabiologiamolecularnaabordagemdasindromedebartterrelatodecaso‏ ‎‡A  Aplicação da biologia molecular na abordagem da síndrome de Bartter: relato de caso‏ ‎‡9  1‏
919 ‎‡a  assessingpreclinicalventriculardysfunctioninobesechildrenandadolescentsthevalueofspeckletrackingimaging‏ ‎‡A  Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging‏ ‎‡9  1‏
919 ‎‡a  associationbetweendyslipidemiaandccl2inpatientsundergoinghemodialysis‏ ‎‡A  Association between dyslipidemia and CCL2 in patients undergoing hemodialysis‏ ‎‡9  1‏
919 ‎‡a  associationofangiotensintype2receptorgenepolymorphismswithureteropelvicjunctionobstructioninbrazilianpatients‏ ‎‡A  Association of angiotensin type 2 receptor gene polymorphisms with ureteropelvic junction obstruction in Brazilian patients‏ ‎‡9  1‏
919 ‎‡a  autoimmunehepatitisandautoimmunehepatitisoverlapwithsclerosingcholangitisimmunophenotypemarkersinchildrenandadolescents‏ ‎‡A  Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and Adolescents‏ ‎‡9  1‏
919 ‎‡a  avaliacaodadoremneonatologia‏ ‎‡A  Avaliação da dor em neonatologia‏ ‎‡9  1‏
919 ‎‡a  barttersyndrome5caseswithdifferentclinicalexpression‏ ‎‡A  [Bartter' syndrome: five cases with different clinical expression]‏ ‎‡9  1‏
919 ‎‡a  bartterssyndromeclinicalfindingsgeneticcausesandtherapeuticapproach‏ ‎‡A  Bartter's syndrome: clinical findings, genetic causes and therapeutic approach‏ ‎‡9  1‏
919 ‎‡a  behavioraldisordersandlowqualityoflifeinchildrenandadolescentswithchronickidneydisease‏ ‎‡A  Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease‏ ‎‡9  1‏
919 ‎‡a  beneficialeffectsoftheactivationoftheangiotensin‏ ‎‡A  Beneficial effects of the activation of the angiotensin-‏ ‎‡9  1‏
919 ‎‡a  beneficialeffectsoftheactivationoftheangiotensin17masreceptorinamurinemodelofadriamycininducednephropathy‏ ‎‡A  Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.‏ ‎‡9  1‏
919 ‎‡a  biomarkersinvesicoureteralrefluxanoverview‏ ‎‡A  Biomarkers in vesicoureteral reflux: an overview‏ ‎‡9  1‏
919 ‎‡a  bonediseaseandcytokinesinidiopathichypercalciuriaareview‏ ‎‡A  Bone disease and cytokines in idiopathic hypercalciuria: a review‏ ‎‡9  1‏
919 ‎‡a  cellderivedmicroparticlesandvonwillebrandfactorinbrazilianrenaltransplantrecipients‏ ‎‡A  Cell-derived microparticles and von Willebrand factor in Brazilian renal transplant recipients‏ ‎‡9  1‏
919 ‎‡a  cerebrospinalfluidlevelsofangiotensinconvertingenzymeareassociatedwithamyloidβ42burdeninalzheimersdisease‏ ‎‡A  Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer’s Disease‏ ‎‡9  1‏
919 ‎‡a  characterizationofanewselectiveantagonistforangiotensin17500pro7angiotensin17‏ ‎‡A  Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7).‏ ‎‡9  1‏
919 ‎‡a  characterizationofanexperimentalmodelofprogressiverenaldiseaseinrats‏ ‎‡A  Characterization of an experimental model of progressive renal disease in rats‏ ‎‡9  1‏
919 ‎‡a  chemokinesaspotentialmarkersinpediatricrenaldiseases‏ ‎‡A  Chemokines as Potential Markers in Pediatric Renal Diseases‏ ‎‡9  1‏
919 ‎‡a  childhoodobesityevidenceofanassociationbetweenplasminogenactivatorinhibitor1levelsandvisceraladiposity‏ ‎‡A  Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity‏ ‎‡9  1‏
919 ‎‡a  circulatingreninangiotensinsysteminchildhoodchronicrenalfailuremarkedincreaseofangiotensin‏ ‎‡A  Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-‏ ‎‡9  1‏
919 ‎‡a  circulatingreninangiotensinsysteminchildhoodchronicrenalfailuremarkedincreaseofangiotensin17inendstagerenaldisease‏ ‎‡A  Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease‏ ‎‡9  1‏
919 ‎‡a  citocinasequimiocinasnotransplanterenal‏ ‎‡A  Citocinas e quimiocinas no transplante renal‏ ‎‡9  1‏
919 ‎‡a  clinicalcharacteristicsandprognosisinchildrenandadolescentswithautoimmunehepatitisandoverlapsyndrome‏ ‎‡A  Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome‏ ‎‡9  1‏
919 ‎‡a  clinicalcourseof822childrenwithprenatallydetectednephrouropathies‏ ‎‡A  Clinical course of 822 children with prenatally detected nephrouropathies‏ ‎‡9  1‏
919 ‎‡a  clinicaloutcomeofchildrenwithchronickidneydiseaseinapredialysisinterdisciplinaryprogram‏ ‎‡A  Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program‏ ‎‡9  1‏
919 ‎‡a  combineduseoflatephasedimercaptosuccinicacidrenalscintigraphyandultrasoundas1linescreeningafterurinarytractinfectioninchildren‏ ‎‡A  Combined Use of Late Phase Dimercapto-Succinic Acid Renal Scintigraphy and Ultrasound as First Line Screening After Urinary Tract Infection in Children‏ ‎‡9  1‏
919 ‎‡a  comparisonofbrazilianresearchersinclinicalmedicinearecriteriaforrankingwelladjusted‏ ‎‡A  Comparison of Brazilian researchers in clinical medicine: are criteria for ranking well-adjusted?‏ ‎‡9  1‏
919 ‎‡a  congenitalanomaliesofthekidneyandurinarytractanembryogeneticreview‏ ‎‡A  Congenital anomalies of the kidney and urinary tract: an embryogenetic review‏ ‎‡9  1‏
919 ‎‡a  currentknowledgeonesophagealatresia‏ ‎‡A  Current knowledge on esophageal atresia‏ ‎‡9  1‏
919 ‎‡a  cytokinesignatureinendstagerenaldiseasepatientsonhemodialysis‏ ‎‡A  Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis.‏ ‎‡9  1‏
919 ‎‡a  cytokinesinchronickidneydiseasepotentiallinkofmcp1anddyslipidemiainglomerulardiseases‏ ‎‡A  Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases‏ ‎‡9  1‏
919 ‎‡a  dentalalterationsinrenaltubularacidosiscasereports‏ ‎‡A  Dental Alterations in Renal Tubular Acidosis: Case Reports‏ ‎‡9  1‏
919 ‎‡a  dentalfindingsinbrazilianpatientswithfanconisyndrome‏ ‎‡A  Dental findings in Brazilian patients with Fanconi syndrome‏ ‎‡9  1‏
919 ‎‡a  dentalmanifestationsin2patientswithbartterssyndrome‏ ‎‡A  Dental Manifestations in Two Patients With Bartter’s Syndrome‏ ‎‡9  1‏
919 ‎‡a  developmentofhepatorenalsyndromeinbileductligatedrats‏ ‎‡A  Development of hepatorenal syndrome in bile duct ligated rats‏ ‎‡9  1‏
919 ‎‡a  diagnosticaccuracyofrenalpelvicdilatationfordetectingsurgicallymanagedureteropelvicjunctionobstruction‏ ‎‡A  Diagnostic accuracy of renal pelvic dilatation for detecting surgically managed ureteropelvic junction obstruction‏ ‎‡9  1‏
919 ‎‡a  diagnosticcriteriaforautoimmunehepatitisinchildrenachallengeforpediatrichepatologists‏ ‎‡A  Diagnostic criteria for autoimmune hepatitis in children: a challenge for pediatric hepatologists‏ ‎‡9  1‏
919 ‎‡a  distalrenaltubularacidosisgeneticcausesandmanagement‏ ‎‡A  Distal renal tubular acidosis: genetic causes and management‏ ‎‡9  1‏
919 ‎‡a  diuresisandnatriuresisproducedbylongtermadministrationofaselectiveangiotensin‏ ‎‡A  Diuresis and natriuresis produced by long term administration of a selective Angiotensin-‏ ‎‡9  1‏
919 ‎‡a  diuresisandnatriuresisproducedbylongtermadministrationofaselectiveangiotensin17antagonistinnormotensiveandhypertensiverats‏ ‎‡A  Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats‏ ‎‡9  1‏
919 ‎‡a  earlyawakeningandextubationwithremifentanilinventilatedprematureneonates‏ ‎‡A  Early awakening and extubation with remifentanil in ventilated premature neonates‏ ‎‡9  1‏
919 ‎‡a  earlychangesinadipokinesfromoverweighttoobesityinchildrenandadolescents‏ ‎‡A  Early changes in adipokines from overweight to obesity in children and adolescents.‏ ‎‡9  1‏
919 ‎‡a  earlyriskfactorsforneonatalmortalityincakutanalysisof524affectednewborns‏ ‎‡A  Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns‏ ‎‡9  1‏
919 ‎‡a  effectofblockadeofnitricoxideinhearttissuelevelsofreninangiotensinsystemcomponentsinacuteexperimentalchagasdisease‏ ‎‡A  Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease‏ ‎‡9  1‏
919 ‎‡a  effectofpropranololonthesplanchnicandperipheralreninangiotensinsystemincirrhoticpatients‏ ‎‡A  Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients‏ ‎‡9  1‏
919 ‎‡a  effectofselectiveangiotensinantagonistsontheantidiuresisproducedbyangiotensin‏ ‎‡A  Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-‏ ‎‡9  1‏
919 ‎‡a  effectofselectiveangiotensinantagonistsontheantidiuresisproducedbyangiotensin17inwaterloadedrats‏ ‎‡A  Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats‏ ‎‡9  1‏
919 ‎‡a  enzymatichydrolysisofwheyproteinconcentrateeffectofenzymetypeandenzymesubstrateratioonpeptideprofile‏ ‎‡A  Enzymatic hydrolysis of whey protein concentrate: effect of enzyme type and enzyme:substrate ratio on peptide profile‏ ‎‡9  1‏
919 ‎‡a  erratumtomesangialc4ddepositionmaypredictprogressionofkidneydiseaseinpediatricpatientswithiganephropathy‏ ‎‡A  Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy‏ ‎‡9  1‏
919 ‎‡a  evaluationofcreatininebasedandcystatin100basedequationsforestimationofglomerularfiltrationrateintype1diabeticpatients‏ ‎‡A  Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients‏ ‎‡9  1‏
919 ‎‡a  evidenceforaphysiologicalroleofangiotensin‏ ‎‡A  Evidence for a Physiological Role of Angiotensin-‏ ‎‡9  1‏
919 ‎‡a  evidenceforaphysiologicalroleofangiotensin17inthecontrolofhydroelectrolytebalance‏ ‎‡A  Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance‏ ‎‡9  1‏
919 ‎‡a  evidenceforaroleofangiotensinconvertingenzyme2inproteinuriaofidiopathicnephroticsyndrome‏ ‎‡A  Evidence for a role of Angiotensin Converting Enzyme 2 in proteinuria of idiopathic nephrotic syndrome‏ ‎‡9  1‏
919 ‎‡a  evidenceforinteractionsbetweeninflammatorymarkersandreninangiotensinsystemmoleculesintheoccurrenceofalbuminuriainchildrenwithsicklecellanemia‏ ‎‡A  Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia‏ ‎‡9  1‏
919 ‎‡a  1reportofcollapsingvariantoffocalsegmentalglomerulosclerosistriggeredbyarbovirusdengueandzikavirusinfection‏ ‎‡A  First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection.‏ ‎‡9  1‏
919 ‎‡a  frequencyofoverweightandobesityinchildrenandadolescentswithautismandattentiondeficithyperactivitydisorder‏ ‎‡A  Frequency of overweight and obesity in children and adolescents with autism and attention deficit/hyperactivity disorder‏ ‎‡9  1‏
919 ‎‡a  geneticdeletionoftheangiotensin‏ ‎‡A  Genetic deletion of the angiotensin-‏ ‎‡9  1‏
919 ‎‡a  geneticdeletionoftheangiotensin17receptormasleadstoglomerularhyperfiltrationandmicroalbuminuria‏ ‎‡A  Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.‏ ‎‡9  1‏
919 ‎‡a  glomerularhyperfiltrationandβ2microglobulinasbiomarkersofincipientrenaldysfunctionincancersurvivors‏ ‎‡A  Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors‏ ‎‡9  1‏
919 ‎‡a  hemodialysisvascularaccessthrombosistheroleoffactor5leidenprothrombingenemutationandabobloodgroups‏ ‎‡A  Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.‏ ‎‡9  1‏
919 ‎‡a  hemostaticchangesinpatientswithendstagerenaldiseaseundergoinghemodialysis‏ ‎‡A  Hemostatic changes in patients with end stage renal disease undergoing hemodialysis‏ ‎‡9  1‏
919 ‎‡a  hemostaticparametersaccordingtorenalfunctionandtimeaftertransplantationinbrazilianrenaltransplantedpatients‏ ‎‡A  Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients‏ ‎‡9  1‏
919 ‎‡a  hepatorenalsyndromeinchildrenareview‏ ‎‡A  Hepatorenal syndrome in children: a review‏ ‎‡9  1‏
919 ‎‡a  imagingforevaluationofurologicabnormalitiesininfantswithfetalhydronephrosisadvancesandcontroversies‏ ‎‡A  Imaging for evaluation of urologic abnormalities in infants with fetal hydronephrosis: advances and controversies‏ ‎‡9  1‏
919 ‎‡a  immunebasedtherapiesfortraumaticbraininjuryinsightsfrompreclinicalstudies‏ ‎‡A  Immune-Based Therapies for Traumatic Brain Injury: Insights from pre-clinical studies‏ ‎‡9  1‏
919 ‎‡a  immunemarkersintherasopathyneurofibromatosistype1‏ ‎‡A  Immune markers in the RASopathy neurofibromatosis type 1.‏ ‎‡9  1‏
919 ‎‡a  immunemediatorsinidiopathicnephroticsyndromeevidenceforarelationbetweeninterleukin8andproteinuria‏ ‎‡A  Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria‏ ‎‡9  1‏
919 ‎‡a  immunestatusofpatientswithhaemophiliaabeforeexposuretofactor81resultsfromthehemfilstudy‏ ‎‡A  Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study.‏ ‎‡9  1‏
919 ‎‡a  immunoglobulinanephropathyapathophysiologyview‏ ‎‡A  Immunoglobulin A nephropathy: a pathophysiology view‏ ‎‡9  1‏
919 ‎‡a  immunoglobulinanephropathypathologicalmarkersofrenalsurvivalinpaediatricpatients‏ ‎‡A  Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients‏ ‎‡9  1‏
919 ‎‡a  inmemoriamprofessorjosesilveriosantosdiniz‏ ‎‡A  [In memoriam: Professor José Silvério Santos Diniz‏ ‎‡9  1‏
919 ‎‡a  inmemoriamprofessorjosesilveriosantosdiniz1935‏ ‎‡A  [In memoriam: Professor José Silvério Santos Diniz (1935-2011)].‏ ‎‡9  1‏
919 ‎‡a  increasedmigratoryandactivationcellmarkersofperipheralbloodlymphocytesinanexperimentalmodelofnephroticsyndrome‏ ‎‡A  Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome‏ ‎‡9  1‏
919 ‎‡a  inflamacaonadoencarenalcronicapapeldecitocinas‏ ‎‡A  Inflamação na doença renal crônica: papel de citocinas‏ ‎‡9  1‏
919 ‎‡a  inflammatorymoleculesandneurotrophicfactorsasbiomarkersofneuropsychomotordevelopmentinpretermneonatesasystematicreview‏ ‎‡A  Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review.‏ ‎‡9  1‏
919 ‎‡a  influenceoface1500polymorphismoncirculatinglevelsofplasminogenactivatorinhibitor1500dimerultrasensitive100reactiveproteinandtransforminggrowthfactorβ1inpatientsundergoinghemodialysis‏ ‎‡A  Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis‏ ‎‡9  1‏
919 ‎‡a  interactionsbetweencytokinescongenitalanomaliesofkidneyandurinarytractandchronickidneydisease‏ ‎‡A  Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease‏ ‎‡9  1‏
919 ‎‡a  interactionsbetweenlocalreninangiotensinsystemandnitricoxideinthebrainoftrypanosomacruziinfectedrats‏ ‎‡A  Interactions between local renin angiotensin system and nitric oxide in the brain of Trypanosoma cruzi infected rats‏ ‎‡9  1‏
919 ‎‡a  iscd44inglomerularparietalepithelialcellsapathologicalmarkerofrenalfunctiondeteriorationinprimaryfocalsegmentalglomerulosclerosis‏ ‎‡A  Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?‏ ‎‡9  1‏
919 ‎‡a  isremifentanilanoptionforpremedicationforneonatalendotrachealintubation‏ ‎‡A  Is remifentanil an option for premedication for neonatal endotracheal intubation?‏ ‎‡9  1‏
919 ‎‡a  isthereacorrelationbetweenjournalimpactfactorandresearchersperformanceastudycomprisingthefieldsofclinicalnephrologyandneurosciences‏ ‎‡A  Is there a correlation between journal impact factor and researchers’ performance? A study comprising the fields of clinical nephrology and neurosciences‏ ‎‡9  1‏
919 ‎‡a  kidneybrainaxisinflammatorycrosstalkfrombenchtobedside‏ ‎‡A  Kidney-brain axis inflammatory cross-talk: from bench to bedside‏ ‎‡9  1‏
919 ‎‡a  liddlessyndromelatediagnosisofararecauseofarterialhypertension‏ ‎‡A  Liddle's syndrome: late diagnosis of a rare cause of arterial hypertension‏ ‎‡9  1‏
919 ‎‡a  lowurinarylevelsofangiotensinconvertingenzyme2maycontributetoalbuminuriainchildrenwithsicklecellanaemia‏ ‎‡A  Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia‏ ‎‡9  1‏
919 ‎‡a  lowercirculatinglevelsofangiotensinconvertingenzyme‏ ‎‡A  Lower circulating levels of angiotensin-converting enzyme‏ ‎‡9  1‏
919 ‎‡a  lowercirculatinglevelsofangiotensinconvertingenzymeaceinpatientswithschizophrenia‏ ‎‡A  Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia‏ ‎‡9  1‏
919 ‎‡a  masandinflammation‏ ‎‡A  Mas and Inflammation‏ ‎‡9  1‏
919 ‎‡a  masinthekidney‏ ‎‡A  Mas in the Kidney‏ ‎‡9  1‏
919 ‎‡a  mascaralaringeaprosealtmcomoviadeadministracaodesurfactantenotratamentodasindromedodesconfortorespiratorioemrecemnascidopretermo‏ ‎‡A  Máscara laríngea ProSealTM como via de administração de surfactante no tratamento da síndrome do desconforto respiratório em recém-nascido pré-termo‏ ‎‡9  1‏
919 ‎‡a  mesangialc4ddepositionmaypredictprogressionofkidneydiseaseinpediatricpatientswithiganephropathy‏ ‎‡A  Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy‏ ‎‡9  1‏
919 ‎‡a  morphineversusremifentanilforintubatingpretermneonates‏ ‎‡A  Morphine versus remifentanil for intubating preterm neonates‏ ‎‡9  1‏
919 ‎‡a  neuropsychiatricdisordersandrenaldiseasesanupdate‏ ‎‡A  Neuropsychiatric disorders and renal diseases: an update‏ ‎‡9  1‏
919 ‎‡a  neurotrophicfactorsinparkinsonsdiseasewhathavewelearnedfrompreclinicalandclinicalstudies‏ ‎‡A  Neurotrophic Factors in Parkinson's Disease: What have we Learned from Pre-Clinical and Clinical Studies?‏ ‎‡9  1‏
919 ‎‡a  newmethodofsurgicaldelayedclosureofgiantomphaloceleslazarodasilvastechnique‏ ‎‡A  New method of surgical delayed closure of giant omphaloceles: Lazaro da Silva's technique‏ ‎‡9  1‏
919 ‎‡a  newerdopplerechocardiographytechniquesinassessmentofheartfunctioninobesepatients‏ ‎‡A  Newer Doppler echocardiography techniques in assessment of heart function in obese patients‏ ‎‡9  1‏
919 ‎‡a  nonpeptideave0991isanangiotensin‏ ‎‡A  Nonpeptide AVE 0991 is an angiotensin-‏ ‎‡9  1‏
919 ‎‡a  nonpeptideave0991isanangiotensin17receptormasagonistinthemousekidney‏ ‎‡A  Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.‏ ‎‡9  1‏
919 ‎‡a  nutritionalevaluationofchildrenwithchroniccholestaticdisease‏ ‎‡A  Nutritional evaluation of children with chronic cholestatic disease‏ ‎‡9  1‏
919 ‎‡a  pathophysiologyofarterialhypertensioninsightsfrompediatricstudies‏ ‎‡A  Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies‏ ‎‡9  1‏
919 ‎‡a  pax2polymorphismsandcongenitalabnormalitiesofthekidneyandurinarytractinabrazilianpediatricpopulationevidenceforaroleinvesicoureteralreflux‏ ‎‡A  PAX2 polymorphisms and congenital abnormalities of the kidney and urinary tract in a Brazilian pediatric population: evidence for a role in vesicoureteral reflux‏ ‎‡9  1‏
919 ‎‡a  pediatriclupusnephritis‏ ‎‡A  Pediatric lupus nephritis‏ ‎‡9  1‏
919 ‎‡a  pediatricpatientswithsteroidsensitivenephroticsyndromehavehigherexpressionoftregulatorylymphocytesincomparisontosteroidresistantdisease‏ ‎‡A  Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease‏ ‎‡9  1‏
919 ‎‡a  perfileanalisedaproducaocientifica2pesquisadoresbrasileirosemneurocienciaclinica‏ ‎‡A  Perfil e análise da produção científica dos pesquisadores brasileiros em Neurociência Clínica‏ ‎‡9  1‏
919 ‎‡a  peripherallevelsofangiotensinsareassociatedwithdepressivesymptomsinparkinsonsdisease‏ ‎‡A  Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease‏ ‎‡9  1‏
919 ‎‡a  physicalexerciseandace2angiotensin‏ ‎‡A  Physical Exercise and ACE2-Angiotensin-‏ ‎‡9  1‏
919 ‎‡a  physicalexerciseandace2angiotensin17masreceptoraxisofthereninangiotensinsystem‏ ‎‡A  Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System‏ ‎‡9  1‏
919 ‎‡a  plasmaandcerebrospinalfluidlevelsofcytokinesasdiseasemarkersofneurologicmanifestationinlongtermhtlv1infectedindividuals‏ ‎‡A  Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals.‏ ‎‡9  1‏
919 ‎‡a  plasmaandurinarylevelsofcytokinesinpatientswithidiopathichypercalciuria‏ ‎‡A  Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria‏ ‎‡9  1‏
919 ‎‡a  plasmalevelsofalarminil33areunchangedinautismspectrumdisorderapreliminarystudy‏ ‎‡A  Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: a preliminary study‏ ‎‡9  1‏
919 ‎‡a  posteriorurethralvalveinfetusesevidencefortheroleofinflammatorymolecules‏ ‎‡A  Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules‏ ‎‡9  1‏
919 ‎‡a  posteriorurethralvalvescomparisonofclinicaloutcomesbetweenpostnatalandantenatalcohorts‏ ‎‡A  Posterior urethral valves: comparison of clinical outcomes between postnatal and antenatal cohorts‏ ‎‡9  1‏
919 ‎‡a  potentialroleofnutrientintakeandmalnutritionaspredictorsofuremicoxidativetoxicityinpatientswithendstagerenaldisease‏ ‎‡A  Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease‏ ‎‡9  1‏
919 ‎‡a  predictivefactorsofchronickidneydiseaseinseverevesicoureteralreflux‏ ‎‡A  Predictive factors of chronic kidney disease in severe vesicoureteral reflux‏ ‎‡9  1‏
919 ‎‡a  predictivefactorsofprogressiontochronickidneydiseasestage5inapredialysisinterdisciplinaryprogramme‏ ‎‡A  Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme‏ ‎‡9  1‏
919 ‎‡a  primaryversussecondaryhypertensioninchildrenfollowedupatanoutpatienttertiaryunit‏ ‎‡A  Primary versus secondary hypertension in children followed up at an outpatient tertiary unit‏ ‎‡9  1‏
919 ‎‡a  profileandscientificoutputofresearchersrecipientsofcnpqproductivitygrantinthefieldofmedicine‏ ‎‡A  Profile and scientific output of researchers recipients of CNPq productivity grant in the field of medicine‏ ‎‡9  1‏
919 ‎‡a  profileandscientificproductionofthebraziliancouncilforscientificandtechnologicaldevelopmentcnpqresearchersinthefieldofhematologyoncology‏ ‎‡A  Profile and scientific production of the Brazilian Council for Scientific and Technological Development (CNPq) researchers in the field of Hematology/Oncology‏ ‎‡9  1‏
919 ‎‡a  rasinthecentralnervoussystempotentialroleinneuropsychiatricdisorders‏ ‎‡A  RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders‏ ‎‡9  1‏
919 ‎‡a  recentadvancesintheangiotensinconvertingenzyme2angiotensin‏ ‎‡A  Recent advances in the angiotensin-converting enzyme 2-angiotensin‏ ‎‡9  1‏
919 ‎‡a  recentadvancesintheangiotensinconvertingenzyme2angiotensin17masaxis‏ ‎‡A  Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.‏ ‎‡9  1‏
919 ‎‡a  relationshipbetweenabobloodgroupsandvonwillebrandfactoradamts13andfactor8inpatientsundergoinghemodialysis‏ ‎‡A  Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis‏ ‎‡9  1‏
919 ‎‡a  relationshipbetweenangiotensin‏ ‎‡A  Relationship between angiotensin-‏ ‎‡9  1‏
919 ‎‡a  relationshipbetweenangiotensin17andangiotensin2correlateswithhemodynamicchangesinhumanlivercirrhosis‏ ‎‡A  Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis‏ ‎‡9  1‏
919 ‎‡a  remifentanilforsedationandanalgesiainapretermneonatewithrespiratorydistresssyndrome‏ ‎‡A  Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome‏ ‎‡9  1‏
919 ‎‡a  renalactionsofangiotensin‏ ‎‡A  Renal actions of angiotensin-‏ ‎‡9  1‏
919 ‎‡a  renalactionsofangiotensin17‏ ‎‡A  Renal actions of angiotensin-(1-7).‏ ‎‡9  1‏
919 ‎‡a  renalfunctionintransgenicratsexpressinganangiotensin‏ ‎‡A  Renal function in transgenic rats expressing an angiotensin-‏ ‎‡9  1‏
919 ‎‡a  renalfunctionintransgenicratsexpressinganangiotensin17producingfusionprotein‏ ‎‡A  Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein‏ ‎‡9  1‏
919 ‎‡a  renalsympatheticdenervationforresistanthypertensionwheredowestandaftermorethanadecade‏ ‎‡A  Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsystemandalzheimersdiseasepathophysiologyfromthepotentialinteractionstotherapeuticperspectives‏ ‎‡A  Renin-angiotensin system and Alzheimer's disease pathophysiology: From the potential interactions to therapeutic perspectives‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsystemandcytokinesinchronickidneydiseaseclinicalandexperimentalevidence‏ ‎‡A  Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsysteminliverdiseasesfriendorfoe‏ ‎‡A  Renin angiotensin system in liver diseases: Friend or foe?‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsysteminthepathogenesisofliverfibrosis‏ ‎‡A  Renin-angiotensin system in the pathogenesis of liver fibrosis‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsystemrasandimmunesystemprofileinspecificsubgroupswithcovid19‏ ‎‡A  Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19‏ ‎‡9  1‏
919 ‎‡a  renoprotectiveeffectsofave0991anonpeptidemasreceptoragonistinexperimentalacuterenalinjury‏ ‎‡A  Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury.‏ ‎‡9  1‏
919 ‎‡a  riskfactorsforearlyonsetofdiabeticnephropathyinpediatrictype1diabetes‏ ‎‡A  Risk factors for early onset of diabetic nephropathy in pediatric type 1 diabetes‏ ‎‡9  1‏
919 ‎‡a  riskfactorsforrecurrenturinarytractinfectionsinacohortofpatientswithprimaryvesicoureteralreflux‏ ‎‡A  Risk factors for recurrent urinary tract infections in a cohort of patients with primary vesicoureteral reflux.‏ ‎‡9  1‏
919 ‎‡a  riskofhypertensioninprimaryvesicoureteralreflux‏ ‎‡A  Risk of hypertension in primary vesicoureteral reflux‏ ‎‡9  1‏
919 ‎‡a  sedationandanalgesiainneonatology‏ ‎‡A  [Sedation and analgesia in neonatology.].‏ ‎‡9  1‏
919 ‎‡a  serumlevelsofangiotensinconvertingenzymeasabiomarkerofliverfibrosis‏ ‎‡A  Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis‏ ‎‡9  1‏
919 ‎‡a  sicklecelldiseasenephropathyanupdateonriskfactorsandpotentialbiomarkersinpediatricpatients‏ ‎‡A  Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients‏ ‎‡9  1‏
919 ‎‡a  solubletumornecrosisfactorreceptorsareassociatedwithseverityofkidneydysfunctioninpediatricchronickidneydisease‏ ‎‡A  Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease‏ ‎‡9  1‏
919 ‎‡a  studyoftheassociationbetweenthebmp4geneandcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A  Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract‏ ‎‡9  1‏
919 ‎‡a  successfulmanagementofconcomitantomphaloceleaccessoryhepaticlobeandbiliaryatresiaina44dayoldboy‏ ‎‡A  Successful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy.‏ ‎‡9  1‏
919 ‎‡a  tlymphocyteexpressinginflammatorycytokinesunderliepersistenceofproteinuriainchildrenwithidiopathicnephroticsyndrome‏ ‎‡A  T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome‏ ‎‡9  1‏
919 ‎‡a  antiinflammatorypotentialoface2angiotensin17masreceptoraxisevidencefrombasicandclinicalresearch‏ ‎‡A  The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research‏ ‎‡9  1‏
919 ‎‡a  experimentalmodelofnephroticsyndromeinducedbydoxorubicininrodentsanupdate‏ ‎‡A  The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update‏ ‎‡9  1‏
919 ‎‡a  oxfordclassificationpredictorsofchronickidneydiseaseinpediatricpatientswithiganephropathy‏ ‎‡A  The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy‏ ‎‡9  1‏
919 ‎‡a  pregnancyinducedincreaseofplasmaangiotensin‏ ‎‡A  The pregnancy-induced increase of plasma angiotensin-‏ ‎‡9  1‏
919 ‎‡a  pregnancyinducedincreaseofplasmaangiotensin17isbluntedingestationaldiabetes‏ ‎‡A  The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes‏ ‎‡9  1‏
919 ‎‡a  protectivearmofthereninangiotensinsystemmaycounteracttheintenseinflammatoryprocessinfetuseswithposteriorurethralvalves‏ ‎‡A  The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinaldosteronesystemin2011roleinhypertensionandchronickidneydisease‏ ‎‡A  The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsystemandbipolardisorderasystematicreview‏ ‎‡A  The Renin Angiotensin System and Bipolar Disorder: A Systematic Review‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsystemandthecerebrovasculardiseasesexperimentalandclinicalevidence‏ ‎‡A  The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsysteminaratmodelofhepaticfibrosisevidenceforaprotectiveroleofangiotensin‏ ‎‡A  The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsysteminaratmodelofhepaticfibrosisevidenceforaprotectiveroleofangiotensin17‏ ‎‡A  The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsysteminchildhoodhypertensionselectiveincreaseofangiotensin‏ ‎‡A  The renin angiotensin system in childhood hypertension: selective increase of angiotensin-‏ ‎‡9  1‏
919 ‎‡a  reninangiotensinsysteminchildhoodhypertensionselectiveincreaseofangiotensin17inessentialhypertension‏ ‎‡A  The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.‏ ‎‡9  1‏
919 ‎‡a  roleofgeneticandimmunefactorsforthepathogenesisofprimarysclerosingcholangitisinchildhood‏ ‎‡A  The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood‏ ‎‡9  1‏
919 ‎‡a  roleoftheimmunesysteminidiopathicnephroticsyndromeareviewofclinicalandexperimentalstudies‏ ‎‡A  The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies‏ ‎‡9  1‏
919 ‎‡a  therapeuticpotentialofangiotensin17asanovelreninangiotensinsystemmediator‏ ‎‡A  The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator‏ ‎‡9  1‏
919 ‎‡a  therapeuticroleofreninangiotensinsystemblockersinobesityrelatedrenaldisorders‏ ‎‡A  The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders‏ ‎‡9  1‏
919 ‎‡a  typicalfeaturesofamelogenesisimperfectain2patientswithbartterssyndrome‏ ‎‡A  Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter's Syndrome‏ ‎‡9  1‏
919 ‎‡a  updateontheapproachofurinarytractinfectioninchildhood‏ ‎‡A  Update on the approach of urinary tract infection in childhood‏ ‎‡9  1‏
919 ‎‡a  urinarychemokinesandantiinflammatorymoleculesinrenaltransplantedpatientsaspotentialbiomarkersofgraftfunctionaprospectivestudy‏ ‎‡A  Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study‏ ‎‡9  1‏
919 ‎‡a  urinarylevelsofil1βandgdnfinpretermneonatesaspotentialbiomarkersofmotordevelopmentaprospectivestudy‏ ‎‡A  Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.‏ ‎‡9  1‏
919 ‎‡a  urinarylevelsoftgfβ1andofcytokinesinpatientswithprenatallydetectednephrouropathies‏ ‎‡A  Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies‏ ‎‡9  1‏
919 ‎‡a  urinarytractinfectioninpediatricsanoverview‏ ‎‡A  Urinary tract infection in pediatrics: an overview‏ ‎‡9  1‏
919 ‎‡a  uromodulinanewbiomarkeroffetalrenalfunction‏ ‎‡A  Uromodulin: a new biomarker of fetal renal function?‏ ‎‡9  1‏
919 ‎‡a  useofdifferentproteasestoobtainwheyproteinconcentratehydrolysateswithinhibitoryactivitytowardangiotensinconvertingenzyme‏ ‎‡A  Use of Different Proteases to Obtain Whey Protein Concentrate Hydrolysates with Inhibitory Activity toward Angiotensin-Converting Enzyme‏ ‎‡9  1‏
919 ‎‡a  usefulnessofpositronemissiontomographyinthedifferentiationbetweentumorandinfectiouslesionsinpediatriconcologyacasereport‏ ‎‡A  Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report‏ ‎‡9  1‏
943 ‎‡a  201x‏ ‎‡A  2011‏ ‎‡9  1‏
946 ‎‡a  a‏ ‎‡9  1‏
996 ‎‡2  BLBNB|000552987‏
996 ‎‡2  LC|n 87816266‏
996 ‎‡2  PTBNP|1599459‏
996 ‎‡2  BNF|16689368‏
996 ‎‡2  NII|DA05689778‏
996 ‎‡2  LNB|LNC10-000139303‏
996 ‎‡2  BLBNB|000275430‏
996 ‎‡2  PLWABN|9812667372405606‏
996 ‎‡2  BLBNB|001554006‏
996 ‎‡2  PTBNP|1860618‏
996 ‎‡2  SZ|1185987754‏
996 ‎‡2  BLBNB|000262577‏
996 ‎‡2  PTBNP|213062‏
996 ‎‡2  LC|n 2012069930‏
996 ‎‡2  DNB|1204223955‏
996 ‎‡2  ISNI|0000000400330253‏
996 ‎‡2  ISNI|0000000067668305‏
996 ‎‡2  LC|n 2006049882‏
996 ‎‡2  ISNI|0000000428114448‏
996 ‎‡2  PTBNP|1452605‏
996 ‎‡2  DNB|1251080022‏
996 ‎‡2  BLBNB|001575463‏
996 ‎‡2  BLBNB|001570612‏
996 ‎‡2  LC|nb2011007052‏
996 ‎‡2  ISNI|0000000123305702‏
996 ‎‡2  PTBNP|1358761‏
996 ‎‡2  LC|n 2022251246‏
996 ‎‡2  PTBNP|1834160‏
996 ‎‡2  DNB|1205114629‏
996 ‎‡2  ISNI|000000006743084X‏
996 ‎‡2  PTBNP|1458059‏
996 ‎‡2  PTBNP|1626884‏
996 ‎‡2  BLBNB|001457558‏
996 ‎‡2  BLBNB|001541517‏
996 ‎‡2  ISNI|0000000070019146‏
996 ‎‡2  BLBNB|000505768‏
996 ‎‡2  PTBNP|1657018‏
996 ‎‡2  BLBNB|000489486‏
996 ‎‡2  NII|DA17770953‏
996 ‎‡2  ISNI|0000000114101900‏
996 ‎‡2  ISNI|0000000068281911‏
996 ‎‡2  LC|n 95910490‏
996 ‎‡2  PTBNP|1510028‏
996 ‎‡2  BLBNB|000556822‏
996 ‎‡2  NLA|000035273522‏
996 ‎‡2  ISNI|0000000101224311‏
996 ‎‡2  ISNI|0000000501456939‏
996 ‎‡2  LC|n 2006210628‏
996 ‎‡2  DNB|1333261616‏
996 ‎‡2  BLBNB|001476433‏
996 ‎‡2  BLBNB|001480368‏
996 ‎‡2  NTA|298907755‏
996 ‎‡2  ISNI|0000000111217537‏
996 ‎‡2  PTBNP|145257‏
996 ‎‡2  PTBNP|1620960‏
996 ‎‡2  ISNI|0000000029940777‏
996 ‎‡2  PTBNP|1303223‏
996 ‎‡2  ISNI|0000000070099828‏
996 ‎‡2  LC|n 89298396‏
996 ‎‡2  PTBNP|172181‏
996 ‎‡2  ISNI|0000000427579454‏
996 ‎‡2  LC|no2019134624‏
996 ‎‡2  RERO|A027149798‏
996 ‎‡2  BLBNB|000184655‏
996 ‎‡2  PTBNP|169674‏
996 ‎‡2  PTBNP|1618187‏
996 ‎‡2  DNB|1191839109‏
996 ‎‡2  PTBNP|713538‏
996 ‎‡2  ISNI|0000000082527703‏
996 ‎‡2  BIBSYS|1634281496246‏
996 ‎‡2  PTBNP|1600904‏
996 ‎‡2  ISNI|0000000054975496‏
996 ‎‡2  DNB|115715851X‏
996 ‎‡2  DNB|1219248169‏
996 ‎‡2  DNB|1231837802‏
996 ‎‡2  PLWABN|9813211183605606‏
996 ‎‡2  SZ|1206346442‏
996 ‎‡2  CAOONL|ncf12034707‏
996 ‎‡2  PTBNP|1809085‏
996 ‎‡2  PTBNP|1483891‏
996 ‎‡2  PTBNP|113153‏
996 ‎‡2  J9U|987007274065305171‏
996 ‎‡2  LC|n 2024254835‏
996 ‎‡2  BNF|16641238‏
996 ‎‡2  PTBNP|1687002‏
996 ‎‡2  NUKAT|n 2010158657‏
996 ‎‡2  BLBNB|000612272‏
996 ‎‡2  BNF|14593283‏
996 ‎‡2  LC|n 2014203915‏
996 ‎‡2  PTBNP|869713‏
996 ‎‡2  SUDOC|251638472‏
996 ‎‡2  PLWABN|9811471554305606‏
996 ‎‡2  PTBNP|1238909‏
996 ‎‡2  PTBNP|1233267‏
996 ‎‡2  LC|n 2023251586‏
996 ‎‡2  BLBNB|000438719‏
996 ‎‡2  PTBNP|1844721‏
996 ‎‡2  PTBNP|277213‏
996 ‎‡2  BLBNB|001529932‏
996 ‎‡2  DNB|1292267453‏
996 ‎‡2  PTBNP|1145571‏
996 ‎‡2  LC|no2024009901‏
996 ‎‡2  ISNI|0000000374543473‏
996 ‎‡2  BLBNB|001519977‏
996 ‎‡2  NUKAT|n 2009163135‏
996 ‎‡2  SUDOC|190623985‏
996 ‎‡2  PTBNP|1663880‏
996 ‎‡2  DNB|1060699974‏
996 ‎‡2  BLBNB|001523427‏
996 ‎‡2  SUDOC|161762670‏
996 ‎‡2  BLBNB|000524258‏
996 ‎‡2  ISNI|0000000068295731‏
996 ‎‡2  DNB|1229839933‏
996 ‎‡2  DNB|1324718919‏
996 ‎‡2  PTBNP|1422620‏
996 ‎‡2  ISNI|0000000080886286‏
996 ‎‡2  PTBNP|221766‏
996 ‎‡2  PTBNP|73762‏
996 ‎‡2  PTBNP|951698‏
996 ‎‡2  BLBNB|000352257‏
996 ‎‡2  BLBNB|001572937‏
996 ‎‡2  LC|n 2010202038‏
996 ‎‡2  BLBNB|001475652‏
996 ‎‡2  ISNI|0000000069813297‏
996 ‎‡2  DNB|1018327266‏
996 ‎‡2  ISNI|000000007023708X‏
996 ‎‡2  PTBNP|1011993‏
996 ‎‡2  PTBNP|73968‏
996 ‎‡2  LC|no 00047912‏
996 ‎‡2  ISNI|0000000070397681‏
996 ‎‡2  ISNI|0000000111431824‏
996 ‎‡2  BLBNB|000423422‏
996 ‎‡2  LC|nr 94026954‏
996 ‎‡2  SUDOC|072481218‏
996 ‎‡2  BLBNB|000987715‏
996 ‎‡2  PTBNP|1402744‏
996 ‎‡2  LC|no2006118323‏
996 ‎‡2  ISNI|0000000070614965‏
996 ‎‡2  PTBNP|1767439‏
996 ‎‡2  NTA|421579552‏
996 ‎‡2  PTBNP|1902662‏
996 ‎‡2  ISNI|000000011585754X‏
996 ‎‡2  SUDOC|164117318‏
996 ‎‡2  LC|nb2014014975‏
996 ‎‡2  PTBNP|1339071‏
996 ‎‡2  LC|n 2009220968‏
996 ‎‡2  PTBNP|1493367‏
996 ‎‡2  ISNI|000000051439129X‏
996 ‎‡2  NTA|203884957‏
996 ‎‡2  SUDOC|237722852‏
996 ‎‡2  RERO|A012553159‏
996 ‎‡2  SUDOC|133804321‏
996 ‎‡2  BLBNB|001510713‏
996 ‎‡2  BLBNB|001129691‏
996 ‎‡2  ISNI|0000000036178338‏
996 ‎‡2  BLBNB|001429300‏
996 ‎‡2  SUDOC|259281271‏
996 ‎‡2  ISNI|0000000068112448‏
996 ‎‡2  LC|n 82125070‏
996 ‎‡2  BLBNB|000371046‏
996 ‎‡2  PTBNP|105363‏
996 ‎‡2  ISNI|0000000068913536‏
996 ‎‡2  ISNI|0000000069294132‏
996 ‎‡2  ISNI|0000000068174091‏
996 ‎‡2  ISNI|0000000039010960‏
996 ‎‡2  NTA|422949795‏
996 ‎‡2  PTBNP|1733715‏
996 ‎‡2  BLBNB|000350561‏
996 ‎‡2  NTA|070055645‏
996 ‎‡2  BLBNB|001538060‏
996 ‎‡2  BLBNB|001590114‏
996 ‎‡2  ISNI|0000000070398000‏
996 ‎‡2  CAOONL|ncf11968826‏
996 ‎‡2  PTBNP|1750509‏
996 ‎‡2  ISNI|0000000081325034‏
996 ‎‡2  ISNI|0000000046636064‏
996 ‎‡2  ISNI|0000000428275866‏
996 ‎‡2  LC|no2014160488‏
996 ‎‡2  ISNI|0000000077588149‏
996 ‎‡2  PTBNP|1339524‏
996 ‎‡2  BNF|17933761‏
996 ‎‡2  BLBNB|000372741‏
996 ‎‡2  DNB|1218560037‏
996 ‎‡2  LC|n 2015235604‏
996 ‎‡2  DNB|1254074392‏
996 ‎‡2  DNB|124910839X‏
996 ‎‡2  RERO|A023738957‏
996 ‎‡2  SUDOC|224522124‏
996 ‎‡2  SUDOC|262274221‏
996 ‎‡2  DNB|1089623151‏
996 ‎‡2  PTBNP|1683489‏
996 ‎‡2  PLWABN|9811302118705606‏
996 ‎‡2  BNF|12282742‏
996 ‎‡2  BLBNB|000603813‏
996 ‎‡2  PTBNP|1431048‏
996 ‎‡2  LC|no2017041559‏
996 ‎‡2  PTBNP|1887809‏
996 ‎‡2  DNB|1056231262‏
996 ‎‡2  NSK|000505712‏
996 ‎‡2  SUDOC|254658881‏
996 ‎‡2  LC|n 2013186072‏
996 ‎‡2  ISNI|0000000044363373‏
996 ‎‡2  PTBNP|1851295‏
996 ‎‡2  BNE|XX1411843‏
996 ‎‡2  BLBNB|001029724‏
996 ‎‡2  LC|no2022006047‏
996 ‎‡2  J9U|987012501074305171‏
996 ‎‡2  PTBNP|967852‏
996 ‎‡2  DNB|112928610X‏
996 ‎‡2  DNB|1068798696‏
996 ‎‡2  PTBNP|266171‏
996 ‎‡2  BLBNB|000262150‏
996 ‎‡2  PTBNP|68151‏
996 ‎‡2  LC|n 2016185333‏
996 ‎‡2  BLBNB|001455954‏
996 ‎‡2  ISNI|0000000031515980‏
996 ‎‡2  LC|no2011171638‏
996 ‎‡2  ISNI|0000000047770847‏
996 ‎‡2  ISNI|0000000034792836‏
996 ‎‡2  SUDOC|136738230‏
996 ‎‡2  ISNI|0000000076937319‏
996 ‎‡2  NUKAT|n 2008089705‏
996 ‎‡2  LC|no2022092465‏
996 ‎‡2  RERO|A026226967‏
996 ‎‡2  ISNI|0000000070513435‏
996 ‎‡2  LC|no2004066431‏
996 ‎‡2  BLBNB|000521626‏
996 ‎‡2  PTBNP|1901159‏
996 ‎‡2  PTBNP|1497071‏
996 ‎‡2  PTBNP|1351981‏
996 ‎‡2  J9U|987007372095205171‏
996 ‎‡2  LC|no2017149185‏
996 ‎‡2  ISNI|0000000079920512‏
996 ‎‡2  BIBSYS|99055241‏
996 ‎‡2  BLBNB|000534747‏
996 ‎‡2  BNCHL|10000000000000000269000‏
996 ‎‡2  BLBNB|000246553‏
996 ‎‡2  ISNI|0000000069516217‏
996 ‎‡2  LC|no2015040128‏
996 ‎‡2  PTBNP|1497415‏
996 ‎‡2  PTBNP|1420479‏
996 ‎‡2  PTBNP|178550‏
996 ‎‡2  LC|n 2022250712‏
996 ‎‡2  PTBNP|1567618‏
996 ‎‡2  BIBSYS|1015219‏
996 ‎‡2  BLBNB|001576133‏
996 ‎‡2  ISNI|0000000068584285‏
996 ‎‡2  NUKAT|n 2021007740‏
996 ‎‡2  LC|n 2007214420‏
996 ‎‡2  DNB|122891333‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏